text.skipToContent text.skipToNavigation
Need help? Please contact us
  1. Home
  2. cd34+

You searched for "cd34+"

89 Products found
Too many choices? Use the filter option on the left to narrow your product listing.
  • 1(current)
  • 2
  • 3

You searched for "cd34+"

118 Documents found
  • Inventory - Non-Parenchymal Cells
    Listing of available non-parenchymal cells inventory; updated monthly Jun 7 2018 NPC Inventory
  • Gene Expression Data Differentiated SubQ Adipo
    Lonza_SupplementalCellInfo_Gene_Expression_Data_Differentiated_SubQ_Adipo.xls
  • Inventory - Non-Parenchymal Cells
    Listing of available non-parenchymal cells inventory; updated monthly March 2019 NPC Inventory
  • MDCK II Transfection Protocol - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of MDCK II cells (ECACC) with the Cell Line Nucleofector™ Kit L
  • Genome Editing using Nucleofector™ Technology
    Technical Reference Guide providing a brief introduction to genome editing tools and technical tips for ZFN, TALEN or CRISPR delivery using the Nucleofector™ Technology
  • Synthego_Lonza_Protocol_Genome Editing of Resting T cells
    Technical Protocol on Genome Editing of Resting T cells for associated White Paper "Genome Editing of Resting T cells"
  • TechSheet - Lung Lymphatic Microvascular Endo. Cell Systems
    Technical information sheet for Clonetics™ Lung Lymphatic Microvascular Endothelial Cells
  • TechSheet - Dermal Lymphatic Microvascular Endo. Cell Systems
    Technical information sheet for Clonetics™ Dermal Lymphatic Microvascular Endothelial Cells
  • Transfection Protocol for hT Cells (stim.) - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of stimulated human peripheral blood T cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • A Novel, Chemically Defined, Serum-Free Cell Culture Medium for Expansion of Transfected T Cells
    In this study, we present data generated with TheraPEAK® T-VIVO®, a novel, chemically defined, non-animal origin cell culture medium utilized to grow T cells in the absence of serum, before and after transfection with the Nucleofector® Technology.
  • An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cells
    A strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
  • Cell Culture in a Chemically Defined Environment - Written Summary
    Learn about the benefits of moving to a serum-free and chemically defined T-cell culture process and discover best practices for achieving optimal results in the absence of serum.
  • Nucleofector™ Technology – Guideline for Easy Set Up of RNAi Screening Experiments
    This guideline aims to help researchers in setting up a successful RNAiscreening experiment using the Nucleofector™ 96-well Shuttle™ System. The recommendations are based on our experience gained in using theNucleofector™ 96-well Shuttle™ System for screens with Thermo ScientificsiRNA libraries in difficult-to-transfect Jurkat T cells and primary HUVECcells2, combined with recommendations collected from the literature. It highlights important parameters that may influence the quality of cellbasedscreening results.
  • Transfection Protocol for Human T Cells (Stim.) - 96-well Shuttle™ Device
    Instructions of use for transfection of stimulated peripheral blood human T cells with the P3 Primary Cell 96-well Nucleofector™ Kit
  • Transfection Protocol for hT Cells (unstim.) - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of unstimulated human peripheral blood T cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
  • Gene Expression Differences in Airway Epithelial Cells from Asthma or COPD Donors
    Access to diseased primary cells from patients diagnosed with COPD or asthma provides a convenient, biologically relevant model to assess genetic and in some cases phenotypic changes from normal, healthy donor tissues. In this study, we grew human bronchial epithelial (HBE) cells from normal, COPD-, and asthma-diagnosed human donor lung tissues in an air-liquid interface (ALI) model to assess potential phenotypic changes in vitro as well as provide a differentiated layer of cells to harvest for gene expression studies using the StellARray™ Gene Expression System.
  • Discover the Freshness of Frozen PBMCs
    An Assessment of Cryopreservation Impact on T Cell Activation
  • Transfection Protocol for Human T Cells (Stim.) - 4D-Nucleofector™ Device
    Instructions of use for transfection of stimulated peripheral blood human T cells with the P3 Primary Cell 4D-Nucleofector™ X Kit
  • Cell-based Assays Using Hard-to-transfect Cell Lines and Transiently Transfected Primary Cells
    Co-sponsered poster with Promega
  • Next Generation 4D-Nucleofector System Toss Sheet
    See at-a-glance product characteristics of the next generation 4D-Nucleofector System, including Core Unit, X Unit, Y Unit, LV Unit and 96-well Unit descriptions, data about transferability of Nucleofection conditions and ordering information.
  • 4
  • 5(current)
  • 6